WebDec 14, 2024 · NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the... WebNovaBay Pharmaceuticals, Inc About Technology Brands Investors News Contact TOP About Management Team Board of Directors Contact Us Technology Pure HOCI Brands …
FDA Declines to Review the NovaBay Pharmaceuticals, …
WebEMERYVILLE, Calif., March 23, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2024 after market close on Thursday, March 30, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. … WebNov 29, 2010 · NovaBay Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary and patented Aganocide compounds, which are … crypto mining tablet
NovaBay Pharmaceuticals NYSEAM:NBY Stock Report - Simply …
WebJun 4, 2015 · NovaBay Pharmaceuticals is a biopharmaceutical company focusing commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global,... WebMar 31, 2024 · Gross profit increased by $1.3 million, to $7.8 million for the year ended December 31, 2024, from $6.5 million for the comparable period in 2024, which is a result of the increase in total sales ... WebJun 3, 2015 · NovaBay® Pharmaceuticals, Inc., a biopharmaceutical company commercializing and developing novel approaches for the global eye care market, including revolutionary non-antibiotic antimicrobial products, announces receipt of 510(k) clearance from the Food and Drug Administration (FDA) to market its novel intelli-Case with … crypto mining tax form